Heart failure & cardiomyopathiesCohort study

Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction

JACC Heart FailPublished

  • Retrospective cohort study
  • clinical registry

Authors' conclusion

The authors demonstrate the prevalence and negative prognostic impact of increasingly elevated TRV levels in individuals with reduced LVEF, with a threshold for mortality lying within the range of "borderline risk" PHT.

Study context

Population
Adults with reduced left ventricular ejection fraction (LVEF) (<50%) and recorded TRV, National Echocardiography Database of Australia
Participants
23,675 adults
Exposure
Increasing pulmonary hypertension (PHT) risk categories by TRV vs normal TRV
  • Normaln = 8,801reference
  • Borderlinen = 7,061
  • Intermediaten = 5,676
  • High-riskn = 2,137
Outcome
All-cause mortality
Follow-up
Median 2.9 years (Q1-Q3: 1.0-5.4 years)

Main finding

As reported in the abstract

Mortality (adjusted HR vs normal TRV)
Each group vs normalAdjusted hazard ratio (95% CI)
Borderline
1.31(1.23–1.38)
Intermediate
1.82(1.72–1.93)
High-risk
2.38(2.21–2.56)

Observational data: associations, not effects.

Further findings

Outcomeadjusted HR (95% CI)
Mortality threshold, TRV >2.41 m/s1.18 (1.04–1.33)
OutcomeNormalBorderlineIntermediateHigh-riskEstimate
1- and 5-year actuarial mortality, normal to severely elevated TRV · 1 and 5 years
1-year mortality13.3%Not reported in the abstractNot reported in the abstract41.5%
5-year mortality43.8%Not reported in the abstractNot reported in the abstract81.4%
  • 1- and 5-year actuarial mortality, normal to severely elevated TRV: P < 0.0001

Original publication

Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction. JACC Heart Fail. Published 20 March 2024. doi:10.1016/j.jchf.2024.01.016

Summarised from the published abstract; every number is checked against it